LIPOPROTEIN(A), APOLIPOPROTEIN(A) POLYMORPHISM, AND INSULIN-TREATMENT IN TYPE-II DIABETIC-PATIENTS

被引:10
作者
BUSCAGLIA, P
GAZZARUSO, C
GARZANITI, A
BONETTI, G
FRATINO, P
GEROLDI, D
机构
[1] POLICLIN SAN MATTEO,IRCCS,DEPT INTERNAL MED & MED THERAPEUT,MED CLIN 1,I-27100 PAVIA,ITALY
[2] UNIV PAVIA,POLO UNIV CITTA PAVIA,DEPT INTERNAL MED & MED THERAPEUT,I-27100 PAVIA,ITALY
关键词
D O I
10.2337/diacare.18.8.1202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1202 / 1203
页数:2
相关论文
共 4 条
  • [1] CHARACTERIZATION OF APO(A) POLYMORPHISM BY A MODIFIED IMMUNOBLOTTING TECHNIQUE IN AN ITALIAN POPULATION-SAMPLE
    GEROLDI, D
    BELLOTTI, V
    BUSCAGLIA, P
    BONETTI, G
    GAZZARUSO, C
    CAPRIOLI, A
    FRATINO, P
    [J]. CLINICA CHIMICA ACTA, 1993, 221 (1-2) : 159 - 169
  • [2] LIPOPROTEIN(A) AND INSULIN-TREATMENT IN NIDDM PATIENTS
    GRUDEN, G
    VEGLIO, M
    CAVALLOPERIN, P
    OLIVETTI, C
    MORMILE, A
    CASSADER, M
    PAGANO, G
    [J]. DIABETES CARE, 1994, 17 (09) : 1075 - 1076
  • [3] APOLIPOPROTEINS (A-I, A-II, B), LP(A) LIPOPROTEIN AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN DIABETES-MELLITUS
    SCHERNTHANER, G
    KOSTNER, GM
    DIEPLINGER, H
    PRAGER, R
    MUHLHAUSER, I
    [J]. ATHEROSCLEROSIS, 1983, 49 (03) : 277 - 293
  • [4] IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS
    WOLFFENBUTTEL, BHR
    LEURS, PB
    SELS, JPJE
    RONDASCOLBERS, GJWM
    MENHEERE, PPCA
    KRUSEMAN, ACN
    [J]. DIABETIC MEDICINE, 1993, 10 (05) : 427 - 430